Companies scramble as 'silver tsunami' threatens to drain decades of expertise

US companies face growing pressure as millions of Baby Boomers near retirement. Over the next five years, employers risk losing up to 10% of their workforce due to this demographic shift. Yet many remain unprepared, with 56% lacking a formal succession plan to pass on critical skills and knowledge. The so-called 'silver tsunami' is accelerating, with more than 4 million Baby Boomers reaching retirement age each year until at least 2027. This exodus threatens to drain institutional knowledge just as younger employees, including Gen Z, enter the workforce. Effective succession planning now demands more than informal networks or relying on familiar talent—it requires deliberate, inclusive strategies to develop future leaders.

The biopharmaceutical sector is also at a turning point. Regulators like the FDA and EMA increasingly expect clinical trials to reflect real-world diversity in both design and participation. Achieving this means moving beyond traditional recruitment methods and embedding inclusivity into trial operations. However, available sources show no concrete measures from leading companies to ensure inclusive talent development by 2025. Without structured approaches, marginalised groups may continue to be overlooked in leadership pipelines and critical roles. Knowledge transfer and skill-building have become urgent priorities, yet many organisations still lack clear plans to address the gap.

The retirement wave and regulatory shifts are pushing companies to rethink talent development. Those without inclusive succession strategies risk losing expertise and failing to meet diversity expectations. The next few years will test whether businesses can adapt quickly enough to avoid workforce shortages and compliance challenges.